India’s COVID-19 Tally Crosses 55-Lakh Mark

Coronavirus LIVE: India's COVID-19 Tally Crosses 55-Lakh Mark

Coronavirus cases in India: The total death count stands at 88,935. (File)

New Delhi:

India’s coronavirus tally crossed the 55-lakh mark with a spike of 75,083 cases and 1,053 deaths on Tuesday. However, the country has achieved record recoveries of 1,01,468 COVID-19 patients in the last 24 hours, the Health Ministry data shows. This was the fourth day when the number of daily recoveries is higher than the daily cases. The total death count stands at 88,935.

With almost 45 lakh people (44,97,868) having beaten COVID-19 since the beginning of the pandemic, the overall recovery rate has increased to 80.86 per cent. The active cases in the 24-hour period reduced to 9,75,861, these account for 17.54 per cent of all cases.

Meanwhile, India reported its lowest daily tally of coronavirus cases in almost a month on Tuesday as it prepares for clinical trials of a potential Russian vaccine in the next few weeks.

Federal health data showed 75,083 new cases in the last 24 hours, and 1,053 deaths over the same period.

There have been 5.6 million cases in total in the country, second only behind the United States.

Despite the fall in cases on Tuesday, India is consistently reporting the highest tally of daily cases anywhere in the world as a dense population and often rudimentary healthcare infrastructure hamper attempts to control the pandemic.

On Tuesday drugmaker Dr Reddy’s Laboratories Ltd said it could begin late-stage trials of a vaccine within the next few weeks.

Indian trials of the Sputnik-V vaccine candidate, being developed by Russia’s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr Reddy’s, told Reuters.

Here are the live updates on Coronavirus (Covid-19) cases:

Coronavirus News: Three Punjab Medical Colleges To Participate In Phase-3 Trial Of Covaxin
The Punjab government today said three government medical colleges of the state will participate in the phase 3 trials of the anti-COVID vaccine “Covaxin” being tested by Bharat Biotech Ltd in collaboration with the Indian Council of Medical Research (ICMR), reported news agency PTI. The trials are scheduled to start from October 15, said a government statement. Chief Minister Amarinder Singh, who chaired a COVID review meeting in Chandigarh, directed the Medical Education & Research Department to ensure full care and strict adherence to all precautions during the trials with mandatory consent of the participants.

2,073 new COVID-19 cases reported in Assam on Tuesday. The total cases in the state rise to 1,61,393 including 1,29,130 recoveries and 586 deaths. Active cases stand at 31,674: State Health Minister Himanta Biswa Sarma

Odisha Asks Covid Treatment Centres To Set Up Help Desk For Family Of Patients

Odisha on Tuesday issued anadvisory asking all COVID-19 treatment facilities to set up help desks and provide necessary information to family members of patients, after several people complained that their requests for details were being snubbed by the centres.

The health and family welfare department, in its notification, said similar instructions were given to the medical facilities in the past, but “feedback from attendants and relatives of the patients clearly suggested that the directions were not followed”.

“After careful examination of the matter, the government has come up with some guidelines, to be followed for establishing a dedicated help desk in each COVID-19 facility with immediate effect.

“The facilities (both government and private) should mandatorily establish a 24X7 help desk and have a dedicated phone number, preferably a toll free number, to reply to queries,” the notification said.

The toll-free numbers should be “widely notified to the public”, and the help desk be manned with sufficient people round the clock, the department said.

Source link

Leave a Comment

fifteen − 4 =